Share

Videos

Allergan Unanimously Rejects Revised Valeant Bid

Bloomberg
|
June 10, 2014 AT 8:46 AM
June 10 (Bloomberg) -- Bloomberg’s Betty Liu reports that Allergan’s board has unanimously rejected an improved offer from Valeant, claiming it undervalues the company. She speaks on Bloomberg Television’s “In The Loop.”